1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (6210)
  2. Journal Article (5696)
  3. Review (405)
  4. Book Section (186)
  5. Editorial (186)
  6. Research Letter (169)
  7. Guidelines (86)
  8. Conference Paper (65)
  9. Correspondence (58)
  10. Miscellaneous (17)
  11. Book Whole (9)
Groups
  1. Hematologic Malignancies, Division of (13087)
  2. Department of Medicine (13003)
  3. Center for Hematologic Malignancies (10394)
  4. GSK Faculty (4421)
  5. Adult Leukemia (3582)
  6. Bone Marrow Transplant (2776)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Ross Levine (774)
  4. Andrew Zelenetz (767)
  5. Martin Tallman (649)
  6. Steven Horwitz (645)

More People

Years
  1. 2025 (203)
  2. 2024 (670)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3371)
  2. Journal of Clinical Oncology (1214)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (328)
  5. Haematologica (289)
  6. Bone Marrow Transplantation (238)

More Publications

Publishers
  1. American Society of Hematology (3638)
  2. Elsevier Inc. (1609)
  3. American Society of Clinical Oncology (1266)
  4. Nature Publishing Group (994)
  5. American Association for Cancer Research (637)
  6. Wiley Blackwell (430)

More Publishers

Results (13087)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A new variable to study in transplant: APOE variant status
    Editorial

    Kaito, S.; DeWolf, S.
    Blood (2025)

    Fulltext@MSK | Save
  • Safety of extended pirtobrutinib exposure in relapsed and/or refractory B-cell malignancies
    Journal Article

    Roeker, L. E.; Coombs, C. C.; Shah, N. N.; Jurczak, W.; Woyach, J. A.; Cheah, C. Y.; Patel, K.; Maddocks, K.; Wang, Y.; Zinzani, P. L.; more...
    Acta Haematologica (2025)

    Fulltext@MSK | Save
  • Risk factors associated with sub-optimal outcomes and hematotoxicity following obecabtagene autoleucel (obe-cel) for relapsed/refractory B-cell acute lymphoblastic leukemia (R/R B-ALL)
    Meeting Abstract

    Sandhu, K. S.; Park, J. H.; Shaughnessy, P.; Logan, A. C.; Abedi, M.; Shah, B.; Bishop, M. R.; Deangelo, D. J.; Brugger, W.; Shang, J.; more...
    Transplantation and Cellular Therapy (2025)

    Fulltext@MSK | Save
  • Enhancing the persistence and anti-tumor efficacy of CAR-T and CAR-NK cells through genetic disruption of death receptors
    Meeting Abstract

    Cohen, T. D.; Yi, F.; Zumbo, P.; Etilib, R.; Arkin, H.; Gormally, M.; Hackett, C. S.; Kropp, K.; Etxeberria, I.; Chandran, S. S.; more...
    Transplantation and Cellular Therapy (2025)

    Fulltext@MSK | Save
  • Correlative science from a phase I study of intravesical Fc-optimized anti-CD40 agonist antibody 2141-V11 for non-muscle invasive bladder cancer (NMIBC) unresponsive to bacillus calmette-guerin (BCG)
    Meeting Abstract

    Bochner, B. H.; Alam, S. M.; Blanchard, L.; Yao, N.; Angulo-Lozano, J.; Wong, J.; Knorr, D.; Whiting, K.; Seshan, V.; Donahue, T.; more...
    Urologic Oncology: Seminars and Original Investigations (2025)

    Fulltext@MSK | Save
  • Transcriptional analysis of bladder cancer histologic subtypes reveals novel drug target heterogeneity
    Meeting Abstract

    Tallman, J. E.; Kuo, F.; Koll, F.; Alam, S. M.; Basar, M.; Luo, J.; Gao, S. P.; Tang, X.; Yol, C.; Gokturk, G.; more...
    Urologic Oncology: Seminars and Original Investigations (2025)

    Fulltext@MSK | Save
  • Immunologic correlates in a CIC::DUX4 fusion-positive sarcoma responsive to dual immune checkpoint blockade
    Journal Article

    Babatunde, O. O.; Membribes, S. C.; Anthonescu, C.; Bradic, M.; O'Malley, B.; Linkov, I.; Bartlett, E.; Momtaz, P.; Alektiar, K.; Gounder, M. M.; more...
    npj Precision Oncology (2025)

    Fulltext@MSK | Save
  • A Shared Care Model between community and transplant centers facilitates access to allogeneic and autologous transplantation
    Journal Article

    Fein, J. A.; McAuliffe, A.; Fischer, K.; Brady, O.; Devlin, S. M.; Willumsen, S.; Ozcan, G.; Montanaro, P.; Pristyazhnyuk, Y.; DiGiuseppe, J.; more...
    Leukemia and Lymphoma (2025)

    Fulltext@MSK | Save
  • Multi-institutional analysis of immune-oncology combination therapy for metastatic MiT family translocation renal cell carcinoma
    Journal Article

    Ged, Y.; Touma, A.; Contreras, L. M.; Elias, R.; Van Galen, J.; Cupo, O.; Baraban, E.; Singla, N.; Lee, C. H.; Pal, S.; more...
    Journal of Immunotherapy (2025)

    Fulltext@MSK | Save
  • Improved patient-reported outcomes with post-transplant cyclophosphamide: A quality-of-life evaluation and 2-year outcomes of BMT CTN 1703
    Journal Article

    Holtan, S. G.; Bolanos-Meade, J.; Al Malki, M. M.; Wu, J.; Kitko, C. L.; Reshef, R.; Rezvani, A. R.; Shaffer, B. C.; Solh, M. M.; Yao, J. M.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save